DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
74.09
+1.01 (1.38%)
Feb 23, 2026, 12:18 PM EST - Market open
DexCom Stock Forecast
Stock Price Forecast
The 21 analysts that cover DexCom stock have a consensus rating of "Strong Buy" and an average price target of $85, which forecasts a 14.73% increase in the stock price over the next year. The lowest target is $68 and the highest is $102.
Price Target: $85 (+14.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 11 | 11 | 11 | 11 | 10 |
| Buy | 8 | 6 | 6 | 7 | 8 | 8 |
| Hold | 3 | 3 | 4 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 20 | 21 | 21 | 22 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $82 → $80 | Strong Buy | Reiterates | $82 → $80 | +7.98% | Feb 17, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $99 → $95 | Strong Buy | Maintains | $99 → $95 | +28.22% | Feb 13, 2026 |
| Barclays | Barclays | Sell Maintains $71 → $72 | Sell | Maintains | $71 → $72 | -2.82% | Feb 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $93 → $85 | Buy | Maintains | $93 → $85 | +14.73% | Feb 13, 2026 |
| Mizuho | Mizuho | Buy Maintains $78 → $90 | Buy | Maintains | $78 → $90 | +21.47% | Feb 13, 2026 |
Financial Forecast
Revenue This Year
5.34B
from 4.66B
Increased by 14.46%
Revenue Next Year
6.00B
from 5.34B
Increased by 12.39%
EPS This Year
2.52
from 2.09
Increased by 20.83%
EPS Next Year
3.05
from 2.52
Increased by 20.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.6B | 6.4B | |||
| Avg | 5.3B | 6.0B | |||
| Low | 5.1B | 5.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 20.7% | 20.2% | |||
| Avg | 14.5% | 12.4% | |||
| Low | 8.8% | 5.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.90 | 3.57 | |||
| Avg | 2.52 | 3.05 | |||
| Low | 2.24 | 2.54 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 38.7% | 41.4% | |||
| Avg | 20.8% | 20.6% | |||
| Low | 7.4% | 0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.